Skip to main content

Advertisement

SpringerLink
Log in

Sentinel Node Biopsy is Important in Mastectomy for Ductal Carcinoma In Situ

  • Breast Oncology
  • Original Paper
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

There is uncertainty about the utility of sentinel node biopsy (SNB) for ductal carcinoma in situ (DCIS) and its potential to avoid axillary lymph node dissection (ALND) in patients undergoing mastectomy for DCIS.

Methods

A review was conducted of 179 patients who underwent mastectomy with sentinel node biopsy for DCIS without invasion or microinvasion on premastectomy pathology review.

Results

The sentinel node identification rate was 98.9% (177/179). Twenty (11.3%) of 177 mastectomies for DCIS had a positive SNB: two micrometastasis (pN1mi) and 18 isolated tumor cells [pN0(i+)]. Unsuspected invasive cancer was found in 20 (11.2%) of 179 mastectomies, eight T1mic, five T1a, three T1b, and four T1c tumors. Sentinel nodes were identified in 19 of 20 patients with invasive cancer and four were positive: one pN1mi and three pN0(i+). Eighteen of 19 patients with unsuspected invasive cancer were able to avoid axillary dissection on the basis of SNB results. Of the 159 patients whose final pathology revealed DCIS without invasion, a sentinel node was identified in 158 (99.4%). The SNB was positive in 16 patients (10.1%): one pN1mi and 15 pN0(i+). Three patients underwent ALND on the basis of positive SNBs and in each the SNB was the only positive node.

Conclusions

11% of patients undergoing mastectomy for DCIS were found to have invasive cancer on final pathology. The use of SNB during mastectomy for DCIS allowed nearly all such patients to avoid axillary dissection. These results support routine use of SNB during mastectomy for DCIS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lagios MD, Silverstein MJ. Sentinel node biopsy for patients with DCIS: a dangerous and unwarranted direction. Ann Surg Oncol 2001;8:275–7

    Article  PubMed  CAS  Google Scholar 

  2. Pendas S, Dauway E, Giuliano R, Ku N, Cox CE, Reintgen DS. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000;7:15–20

    Article  PubMed  CAS  Google Scholar 

  3. Klauber-DeMore N, Tan LK, Liberman L, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 2000;7:636–42

    Article  PubMed  CAS  Google Scholar 

  4. Intra M, Veronesi P, Mazzarol G, et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 2003;138:309–13

    Article  PubMed  Google Scholar 

  5. Veronesi P, Intra M, Vento AR, Naninato P, Caldarella P, Paganelli G, Viale G. Sentinel lymph node biopsy for localized ductal carcinoma in situ? Breast 2005;14:520–2

    Article  PubMed  CAS  Google Scholar 

  6. Wilkie C, White L, Dupont E, Cantor A, Cox CE. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg 2005;190:563–6

    Article  PubMed  Google Scholar 

  7. Schwartz GF, Giuliano AE, Veronesi U. Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast, April 19–22, 2001, Philadelphia, Pennsylvania. Cancer 2002;94:2542–51

    Article  PubMed  Google Scholar 

  8. Mabry H, Giuliano AE, Silverstein MJ. What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ? Am J Surg 2006;192:455–7

    Article  PubMed  Google Scholar 

  9. Sakr R, Barranger E, Antoine M, Prugnolle H. Ductal carcinoma in situ: value of sentinel lymph node biopsy. J Surg Oncol 2006;94:426–30

    Article  PubMed  Google Scholar 

  10. Zavagno G, Carcoforo P, Marconato R, et al. Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. BMC Cancer 2005;5:28–33

    Article  PubMed  Google Scholar 

  11. Leidenius M, Salmenkivi K, Von Smitten K, Heikkila P. Tumour-positive sentinel node findings in patients with ductal carcinoma in situ. J Surg Oncol 2006;94:380–4

    Article  PubMed  CAS  Google Scholar 

  12. Guiliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391–401

    Article  Google Scholar 

  13. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864–7

    Article  PubMed  CAS  Google Scholar 

  14. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer—a multicenter validation study. N Engl J Med 1998;339:941–6

    Article  PubMed  CAS  Google Scholar 

  15. Tan JC, McCready DR, Easson AM, Leong WL Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy. Ann Surg Oncol 2007;14:638–45

    Article  PubMed  Google Scholar 

  16. Dupont EL, Kuhn MA, McCann C, Salud C, Spanton JL, Cox CE. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg 2000;180:274–7

    Article  PubMed  CAS  Google Scholar 

  17. Sabel MS, Degnim A, Wilkins EG, Diehl KM, Cimmino VM, Chang AE, Newman LA. Mastectomy and concomitant sentinel lymph node biopsy for invasive breast cancer. Am J Surg 2004;187:673–8

    Article  PubMed  Google Scholar 

  18. Langer S, Guenther JM, Haigh PI, Difronzo. Lymphatic mapping improves staging and reduces morbidity in women undergoing total mastectomy for breast carcinoma. Am Surg 2004;70:881–5

  19. Greene FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging handbook—TNM classification of malignant tumors, 6th ed. New York: Springer Verlag, 2002

    Google Scholar 

  20. Singletary SE, Greene FL, Sobin LH, (eds). Classification of isolated rumor cells. Clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer 2003;12:2704–41

  21. Gadd M, Harris J, Taghian A, Powell S, O’Neill A, Kaelin C, Lesniloski B, Rhei E, Younger J, Winer E, Smith B. Prospective study of axillary radiation without axillary dissection for breast cancer patients with a positive sentinel node. San Antonio Breast Cancer Symposium, San Antonio, Texas, 2005. Avalaible: http://www.abstracts2view.com/sabcs05/view.php?nu = SABCS05L_10190

  22. Thompson M, Korourian S, Henry-Tillman R, Adkins L, Mumford S, Westbrook KC, Klimberg VS. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Onc 2007;14:1890–5

    Article  Google Scholar 

  23. Bleiweiss IJ, Nagi SC, Jaffer S. Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol 2006;24:2013–8

    Article  PubMed  Google Scholar 

  24. Lara J, Young S, Velilla R, Santoro EJ, Templeton SF. The relevance of occult axillary micrometastasis in ductal carcinoma in situ. Cancer 2003;98:2105–13

    Article  PubMed  Google Scholar 

  25. El-Tamer M, Chun J, Gill M, Bassi D, Lee S, Hibshoosh H, Mansukhani M. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ. Ann Surg Oncol 2005;12:254–9

    Article  PubMed  Google Scholar 

  26. Kelly TA, Kim JA, Patrick R, Grundfest S, Crowe JP. Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ. Am J Surg 2003;186:368–70

    Article  PubMed  Google Scholar 

  27. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982;50:1309–14

    Article  PubMed  CAS  Google Scholar 

  28. Hoorntje LE, Schipper MEI, Peeters PHM, Bellot F, Storm RK, Borel Rinkes IHM. The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy. Ann Surg Oncol 2003;10:748–53

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Francisco J. Dominguez MD, Dalliah M. Black MD, Kevin S. Hughes MD, Michele A. Gadd MD, Michelle Specht MD, James Michaelson PhD & Barbara L. Smith MD, PhD

  2. Division of Surgical Oncology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    Mehra Golshan MD, Roger Christian MD & Beth-Ann Lesnikoski MD

Authors
  1. Francisco J. Dominguez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mehra Golshan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dalliah M. Black MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kevin S. Hughes MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michele A. Gadd MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Roger Christian MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Beth-Ann Lesnikoski MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Michelle Specht MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. James Michaelson PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Barbara L. Smith MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barbara L. Smith MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dominguez, F.J., Golshan, M., Black, D.M. et al. Sentinel Node Biopsy is Important in Mastectomy for Ductal Carcinoma In Situ. Ann Surg Oncol 15, 268–273 (2008). https://doi.org/10.1245/s10434-007-9610-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9610-6

Keywords

Search

Navigation